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Abstract
Background: Sandwich enzyme-linked immunosorbent assay (ELISA) is one of the most frequently employed assays for
clinical diagnosis, since this enables the investigator to identify specific protein biomarkers. However, the conventional
assay using a 96-well microtitration plate is time- and sample-consuming, and therefore is not suitable for rapid diagnosis.
To overcome these drawbacks, we performed a sandwich ELISA on a microchip.
Methods and Findings: The microchip was made of cyclic olefin copolymer with straight microchannels that were 300 mm
wide and 100 mm deep. For the construction of a sandwich ELISA for procollagen type I C-peptide (PICP), a biomarker for
bone formation, we used a piezoelectric inkjet printing system for the deposition and fixation of the 1st anti-PICP antibody
on the surface of the microchannel. After the infusion of the mixture of 2.0 ml of peroxidase-labeled 2nd anti-PICP antibody
and 0.4 ml of sample to the microchannel and a 30-min incubation, the substrate for peroxidase was infused into the
microchannel; and the luminescence intensity of each spot of 1st antibody was measured by CCD camera. A linear
relationship was observed between PICP concentration and luminescence intensity over the range of 0 to 600 ng/ml
(r
2=0.991), and the detection limit was 4.7 ng/ml. Blood PICP concentrations of 6 subjects estimated from microchip were
compared with results obtained by the conventional method. Good correlation was observed between methods according
to simple linear regression analysis (R
2=0.9914). The within-day and between-days reproducibilities were 3.2–7.4 and 4.4–
6.8%, respectively. This assay reduced the time for the antigen-antibody reaction to 1/6, and the consumption of samples
and reagents to 1/50 compared with the conventional method.
Conclusion: This assay enabled us to determine serum PICP with accuracy, high sensitivity, time saving ability, and low
consumption of sample and reagents, and thus will be applicable to clinic diagnosis.
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Introduction
Many plasma proteins that have originated from various tissues
or blood cells as a result of secretion or leakage can be used as
biomarkers, and many studies have demonstrated that plasma
protein levels reflect human physiological or pathological states
and can thus be used for disease diagnosis and prognosis [1–3].
The immunoassay is often employed in clinical and experimental
laboratories, since this technique enables the identification of
specific protein biomarkers; and small amounts of target molecules
present in complex biological samples such as blood can be
specifically detected by its use. The double antibody sandwich
technique, the so-called sandwich enzyme-linked immunosorbant
assay (ELISA), is frequently used for antigen measurement [4,5].
This assay is specifically useful for detecting a specific antigen
when only a small amount of it is available and purified antigen is
unavailable. In the conventional sandwich ELISA system,
disposable 96-well microtitration plates are frequently employed
to detect biomarkers in blood. Typically 50-ml aliquots of capture
antibody (1st antibody) and enzyme conjugated antibody (2nd
antibody) to detect antigen, and 50 ml aliquots of antigen solution
are employed in the reaction wells in 96-well microtitration plates
[6]. Furthermore, this method is time-consuming, for the capture
of antigen by 1st antibody and the determination of the antigen
concentration by the 2nd antibody each requires 2 hr or more. So,
the conventional sandwich ELISA is not suitable for rapid
diagnosis.
The analysis of biomarkers at a location near the patient, which
analysis is called point-of care testing (POCT), is a continuously
expanding trend in the practice of laboratory diagnosis [7], and it
is preferred when test results are needed more rapidly than is
feasible by using conventional testing procedures [8–11]. Several
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biological analyses [12–15], and several types of immunoassay on
a microchip have been applied practically in POCT [16–24]. Such
analysis using microchips has many advantages such as high
efficiency, time-saving ability, easy operation, low consumption of
samples and reagents, and easy integration and automation.
Antibody adsorbed to beads-packed in the microchannels have
often been employed for sandwich ELISA [19,21–24]. For these
immunoassays, elaborate microscopic dam-like structures (a few
score or so of mm scale gaps) in the microchannel are needed to
stop these microbeads in suspension from flowing throughout the
microchannel. Recently, inkjet printing systems to deposit and
immobilize an antibody on a nylon membrane were used for
immunoassay application [25]. Inkjet printing allows for the
straightforward deposition of biological materials on the assay
surface. For the development of sandwich ELISA assays on the
microchip, we employed piezoelectric inkjet printing for deposi-
tion and fixation of the 1st antibody on the microchannel surface.
In the present study, the model analyte used was the
carboxyterminal propeptide of type I procollagen (PICP).
Determination of the PICP level is a means of estimating the
rate of type I collagen synthesis in the body, and the serum
concentration of PICP is known to correlate with the rate of bone
formation [26]. Therefore, the serum concentration of PICP can
be used as a biomarker for osteoporosis, and osteoblastic bone
metastases in prostatic cancer. A piezoelectric inkjet printing
system capable of creating sub-millimeter patterns of aqueous
reagent with precise placement for biosensor applications was
recently developed [27]. In the present study anti-PICP 1st
antibody was deposited and fixed on the microchannel surface by
using this inkjet printing technique, and a sandwich ELISA assay
using 0.4 ml of serum for PICP determination was performed in
the microchannel. We examined the feasibility of determining
serum concentration of PICP with this system. The accuracy of
determining the serum concentration of PICP in a microchannel
was comparable to that obtained by the conventional sandwich
ELISA using the 96-well microtitration plates. Furthermore, the
time required for the immunoassay was drastically shortened. We
demonstrated the possible application of microchips for monitor-
ing serum PICP levels and its potential for POCT.
Methods
Principle
Schematic illustrations of sandwich ELISA assay on microchip
for the determination of serum PICP are shown in Fig. 1. The
microchip was made of cyclic olefin copolymer (COC) and was
30 mm long and 60 mm wide. The channels in the microchip
were straight, 300 mm wide, and 100 mm deep. The COC
microchip was fabricated by injection molding with a nickel mold,
and the microchip surface was treated with polymer solution
containing p-nitrophenyl ester which binds to amino groups in
proteins for 1st antibody fixation on microchannel surface (BS-
X2321, SUMITOMO BAKELITE Co., Ltd, Tokyo, Japan). This
microchip was used in this immunoassay for the detection of serum
PICP. Four samples could be analyzed simultaneously on the
microchip. A Pulseinjector (Cluster Technology Co., Ltd., Osaka,
Japan), which is the piezoelectric inkjet printing system, was
employed for the deposition and fixation of the 1st antibody on the
microchannel. The derive waveform C was employed to provide
the volume of droplet, and the droplets were ejected at a frequency
of 20 Hz and a jetting voltage of 14 V. The volume of a single
discharged droplet of 1st antibody was 65 pl, and 100 droplets
were discharged onto the surface of the microchannel to fix the
maximum volume of the 1st antibody as shown in Fig. 1. After the
deposition and fixation of the 1st anti-PICP antibody on the
surface of the microchannel, the microchip surface was sealed by a
cover film made of polymethylmethacrylate and having a 33-mm
thickness and 20-mm adhesion layer (TOYO INK MFG. CO.,
LTD. Tokyo, Japan). All samples and reagents for the sandwich
ELISA assay were infused from reservoirs with a diameter of
1.0 mm (wells 1, 3, 5, and 7) into the microchannels by a pipette.
The reservoirs on the other side were used as waste reservoir (wells
2, 4, 6, and 8).
Reagents and analytical procedure
A procollagen type I C-peptide (PIP) EIA Kit (precoated) was
purchased from TAKARA BIO INC. (Shiga, Japan) and employed
for the determination of the serum concentration of PICP with a
microtitration plate as the conventional method according to the
supplied instructions. Briefly, 100 ml of peroxidase-labeled anti-
PICP 2nd antibody and 20 ml of sample were simultaneously added
to each well of a 96-well microtitration plate that had been
precoated with anti-PICP 1st antibody, and the plate was then
incubated for 3 hr at room temperature. To make a calibration
curve we diluted PICP with sample diluent to 600, 300, and
150 ng/ml; and these were used as samples. For the determination
of the serum concentration of PICP, serum was diluted 5 times with
sample diluent. After the plate had been washed with phosphate-
buffered saline, 100 ml of substrate solution for peroxidase was
added to the wells, and the plate was then incubated for 15 min at
room temperature. After the addition of the stop solution to the
wells, the absorbance of the solution was measured at 450 nm by
using a microplate reader (Tecan Austria GmbH, Salzburg,
Austria). The serum concentration of PICP was calculated from
the standard curve and expressed as ng/ml.
Analysis of PICP on the microchip
For the sandwich ELISA assay on the microchip, we used the
same monoclonal anti-PICP antibodies that were used in the
Procollagen type I C-peptide (PIP) EIA Kit for 96-well of
microtitration plates and substrates. For the deposition and fixation
of 0.1 mg/ml 1st antibody (Clone PC8-7, TAKARA) in spotting
buffer on the surface of the microchannel, a piezoelectric inkjet
printing system (Cluster Technology Co., Ltd. Osaka, Japan) was
employed. A jetting voltage of 14 V for antibody ‘‘inks’’ was used in
this study. The volume of the drop ejected from the inkjet nozzle
was 65 pl, and 100 drops were spotted onto the microchannel
surface,asshowninFigure1.Themicrochipwasthen incubatedfor
4 hr at room temperature. Spots were round with a 250-mm
diameter. After sealing of the microchip surface with the cover film,
blocking solution was infused into each microchannel; and the
microchip was left undisturbed for 1 hr at room temperature.
Washing of the microchannels was performed by infusing the wash
solution into each microchannel. Blocking solution and wash
solution for microchip were purchased from SUMITOMO
BAKELITE Co. Ltd. Then a mixture of 2.0 ml of peroxidase-
labeled 2nd anti-PICP antibody (Clone PC5-5, TAKARA) and
0.4 ml of sample was infused into each microchannel, followed by
incubation at room temperature for 30 min. Samples were
prepared according to the conventional method described above.
To make a calibration curve and to examine the reproducibility in
one channel or different channels, we diluted standard (640 ng/ml
human PICP) with sample diluent to 600, 300, and 150 ng/ml; and
thesewereused assamples.Afterwashingofthe microchannelswith
wash solution, 1.8 ml of substrate solution for the peroxidase
reaction was infused into the microchannels; and the microchip was
incubated for 5 min at room temperature. The integration value of
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Light-Capture (ATTO Corporation, Tokyo, Japan) which has a
resolution of up to 62.5 mm, and analyzed by using CS Analyzer
ver2.0.
Blood sample preparation
Peripheral venous blood samples were collected from healthy
subjects by standard venipuncture. All blood samples were
collected into sterile centrifuge tubes, and the serum were obtained
by centrifugation at 800 x g for 5 min. The serum was then stored
at 280uC until used.
Ethics
This study was approved by the Institutional Review Board on
using human derivatives for biomedical research of National
Institute of Advanced Industrial Science and Technology, and the
Ethical Committee of University of Tokushima. All subjects
provided written informed consent for the collection of samples
and subsequent analysis. No current external funding sources for
this study.
Results
Sandwich ELISA on microchip
We developed a sandwich ELISA on a COC microchip by
depositing and fixing the 1st anti-PICP antibody on the surface of
the microchannel with a piezoelectric inkjet printing system
(Fig. 1). In the present assay, the luminescence intensity increased
in a time-dependent manner after the mixture of peroxidase-
labelled 2nd antibody and sample was introduced into the
microchannel, and a linear relationship was observed until
30 min (data not shown). Therefore, every reaction time for 2nd
antibody and antigen reaction was fixed at 30 min in the present
study. The piezoelectric inkjet printing system was capable of
ejecting a precise droplet volume and placing it precisely in the
microchannel. Reproducibilities of the determination of the PICP
concentration in one channel and different channels were
examined. As shown in Table 1, slight variation of the
luminescence intensity of 3 spots in 1 channel for 0, 150, 300,
and 600 ng/ml PICP was observed, with the relative standard
deviation (RSD) for each concentration being 4.2, 6.0, 8.1, and
7.5%, respectively. This result indicated the possibility of using a
single channel with multi spotting of antibody on the micro-
channel for duplicate, triplicate, quadruplicate or more determi-
nations by using only 1 channel. The RSDs of the luminescence
intensity in 3 different channels for 0, 150, 300, and 600 ng/ml
PICP were 4.0, 5.7, 8.1, and 8.8%, respectively (Table 2). This
result indicated good reproducibility of luminescence intensity
induced by the antigen-antibody reaction even in different
microchannels.
Determination of serum PICP
Quantitative analysis of serum PICP concentrations was
performed next. The relationship between the concentrations of
Figure 1. Schematic process for detection of PICP on a microchip with deposition and fixation of 1st antibody by piezoelectric ink
printing. After fixation of antibody on the surface of the microchannel and sealing with a cover film, blocking solution was infused into each
microchannel from the reservoir (wells 1, 3, 5, and 7) by use of a pipetman.
doi:10.1371/journal.pone.0018807.g001
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intensity derived from peroxidase-conjugated 2nd anti-PICP
antibody was examined (Fig. 2). Three spots of 1st anti-PICP
antibody were deposited into each microchannel for triplicate
determinations, and purified PICP solution (0 to 600 ng/ml) and
peroxidase-labeled 2nd antibody were infused into each micro-
channel. The luminescence increased in a PICP concentration-
dependent manner (Fig. 2A). The mean (6SD) of the lumines-
cence intensity for the 6 different spots at each purified PICP
concentration was obtained and plotted against the dose, giving a
linear relationship between the range of 0–600 ng/ml PICP
(R
2=0.991; Fig. 2B). The detection limit was 4.7 ng/ml. This
range is sufficient for clinical estimation of PICP concentrations in
the blood [28,29]. These data thus strongly indicate that this
sandwich ELISA performed on a microchip with the aid of
piezoelectric printing technology is suitable for the determination
of blood PICP concentrations. Blood PICP concentrations in 6
subjects were then calculated by reference to the standard curve
generated from data obtained from the sandwich ELISA on a
microchip. Each estimated blood PICP concentration was
compared with the results obtained by using the 96-well
microtitration plate commonly used in clinical laboratories. As
shown in Fig. 3, linear regression analysis of these PICP
concentrations obtained by both methods revealed a significant
relationship (R
2=0.9914). This result indicated that accurate
determination of blood PICP could be performed by use of our
new method. Three different samples were analyzed repeatedly
within 1 day or for several days for their PICP concentration
(Table 3). The within-day (n=4) reproducibility was 3.2–9.8%;
and the between-days (n=4) one, 4.4–6.8%. According to the
documentation supplied in the Procollagen type I C-peptide EIA
Kit, the reproducibilities of within-day and between-days were
4.5–7.4% and 4.3–6.3%, respectively, for 3 different subjects when
the conventional microtitration plate was used. Thus the
reproducibility of the sandwich ELISA on a microchip for the
determination of the blood PICP concentration was quite
comparable to that obtained with the conventional 96-well
microtitration plate.
Discussion
To develop our quantitative sandwich ELISA using micro-
channels, we used an inkjet printing system, because it has been
shown to deliver small reagent volumes with precise alignment and
high reproducibility [27]. There are 2 main classes of inkjet
printers, thermal and piezoelectric. In the thermal inkjet printers,
a resistive heating element causes air bubbles to expand, expelling
a liquid drop. On the other hand, voltage-induced deformation of
Table 1. Reproducibility of luminescence intensity of PICP in
1 channel.
Spot number PICP (ng/ml)
0 150 300 600
1 4164 19292 61840 106188
2 3932 19304 62780 102992
3 3840 17352 54020 118584
Average 3979 18649 59547 109255
RSD (%) 4.2 6.0 8.1 7.5
doi:10.1371/journal.pone.0018807.t001
Table 2. Reproducibility of luminescence intensity of PICP in
3 different channels.
Channel number PICP (ng/ml)
0 150 300 600
1 4305 16661 55275 111513
2 4125 17923 65007 128005
3 3979 18649 59547 109255
Average 4136 17744 59943 116258
RSD (%) 4.0 5.7 8.1 8.8
doi:10.1371/journal.pone.0018807.t002
Figure 2. Detection of purified PICP by sandwich ELISA on a microchip. Three deposits of 1st antibody were made into each microchannel,
and 0 to 600 ng/ml PICP and peroxidase-conjugated 2nd antibody solution were then infused, allowing triplicate determinations to be made in 1
channel. (A) The luminescence increased in a PICP concentration-dependent manner. (B) Standard curve for the PICP concentration versus
luminescence intensity obtained by the assay.
doi:10.1371/journal.pone.0018807.g002
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the nozzle in the piezoelectric inkjet printer [30]. Allain et al.
reported that the functionality of deposited biological materials
may be compromised due to the patterning process, particularly in
the case of thermal inkjet printing [31]. Several reports have
shown that the functionality and stability of many biological
materials may be maintained despite the high pressure involved in
piezoelectric inkjet printing [25,27,32,33]. Although immunoassay
was performed with antibody deposition on nylon membrane by
piezoelectric inkjet printing, the quantification was not shown
[25]. In the present study, we employed a commercial piezoelec-
tric inkjet printer to expel the antibody onto the microchip to
avoid thermal damage to the antibody. Therefore, we could
develop a sensitive and accurate sandwich ELISA on the
microchip.
Although we could not compare the consumption of 1st
antibody between the microchip and the microtitration plate
because the 1st antibody had been precoated on the wells for the
conventional method, the use of a microchip has considerable
advantages; low consumption of serum (0.4 ml/microchannel
versus 20 ml/well for 96-well microtitration plate) and of
peroxidase-labeled 2nd antibody and substrate (2.0 ml of each/
microchannel versus 100 ml/well for the plate), ease of operation,
i.e., use of just 1 pipetman for infusion of each solution into the
microchannel; and reduced immunoassay time (30 min for the
microchip versus 3 hr for the plate). Earlier an immunosorbent
assay system was integrated into a microchip, and antibody-
conjugated polystyrene beads were introduced into a microchan-
nel [19,21–23]. The immunoassay time was remarkably reduced
owing to the size effect of the microspace in the microchannel. For
the detection of carcinoembryonic antigen in human sera, the
immunoassay time was reduced to one-ninetieth of that for the
conventional immunoassay with the 96-well microtitration plate
[23]. This effect was obtained by an increase in the specific
interface and a reduction in the diffusion distance by packaging
the 41.7 mm diameter polystyrene beads in the microchannel.
However, the immunoassay time in the present study was reduced
to just one-sixth of that for the conventional immunoassay. This
small reduction in assay time must be due to the smaller effects of
specific interface and reduced diffusion distance than in the case of
using beads in the microchannel. Although there is a remarkable
reduction in immunoassay time when beads are used in a
microchannel, the fabrication of precise dam-like structures in
the microchannel is necessary to package the beads in the
microspace. Precise deposition of antibody on any microchannel
surface is easy with an inkjet printing system, and so there is no
need for special fabrication in the microchannel. Furthermore, the
plural deposition of antibodies on any part of the microchannel
surface, as was shown in Fig. 2A, can be performed. So, the inkjet
printer is easily applicable for multi-analysis of biomarkers by
spotting different kinds of antibodies on 1 channel through the
change of inkjet heads containing the antibody solution. In fact, we
could detect 3 kinds of biomarkers in human blood by multi-
spotting 3 kinds of antibodies on a single channel (data not shown).
In conclusion, we presented a new sandwich ELISA assay
system utilizing a microchip and inkjet printer to detect serum
PICP. The sandwich ELISA performed in a microchannel with
deposition and fixation of the 1st antibody on the microchannel
Figure 3. Comparative analysis of the values obtained with the microchip method and the conventional microtitration plate
method. Linear regression analysis was used.
doi:10.1371/journal.pone.0018807.g003
Table 3. Reproducibility of microchip method for the
determination of PICP in serum samples.
Sample PICP
Mean ± S, ng/ml CV, %
Within day, n=4
1 327.4610.3 3.2
2 479.2647.2 9.8
3 623.7646.4 7.4
Between days, n=4
4 874.5645.0 5.2
5 580.7639.7 6.8
6 657.9628.9 4.4
doi:10.1371/journal.pone.0018807.t003
Immunoassay on Microchip for the Detection of PICP
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18807surface by use of the inkjet printing system offers considerable
advantages, including low consumption of sample and reagent,
reduced immunoassay time, and ease of operation. This assay on a
microchip enables the determination of the blood PICP concen-
tration with high levels of sensitivity, accuracy, and reproducibility,
and is thus applicable to clinical diagnosis.
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